309 related articles for article (PubMed ID: 6196037)
1. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
Schramm M; Thomas G; Towart R; Franckowiak G
Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
[TBL] [Abstract][Full Text] [Related]
2. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
3. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Hattori Y; Nakaya H; Tohse N; Kanno M
J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
Thomas G; Gross R; Schramm M
J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
[TBL] [Abstract][Full Text] [Related]
5. [Effects of a new 1,4-dihydropyridine, Bay K 8644, on smooth muscle organs isolated from the guinea pig].
Lograno M; De Luca A; Persichella M; Conte-Camerino D
Boll Soc Ital Biol Sper; 1986 Apr; 62(4):471-8. PubMed ID: 2427095
[No Abstract] [Full Text] [Related]
6. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.
Kanmura Y; Itoh T; Kuriyama H
J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390
[TBL] [Abstract][Full Text] [Related]
7. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.
Schramm M; Thomas G; Towart R; Franckowiak G
Nature; 1983 Jun 9-15; 303(5917):535-7. PubMed ID: 6190088
[TBL] [Abstract][Full Text] [Related]
8. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
Asano M; Aoki K; Suzuki Y; Matsuda T
J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
[TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
10. Activation of Ca channels in heart muscle by a new dihydropyridine derivative.
Nilius B
Gen Physiol Biophys; 1984 Oct; 3(5):437-40. PubMed ID: 6210228
[No Abstract] [Full Text] [Related]
11. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Ca-dependent action potentials in mammalian ventricular myocardium by a novel dihydropyridine.
Nilius B
Biomed Biochim Acta; 1984; 43(12):1385-97. PubMed ID: 6085472
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs.
Gross R; Kayser M; Schramm M; Taniel R; Thomas G
Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):203-16. PubMed ID: 2415078
[TBL] [Abstract][Full Text] [Related]
14. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
Franckowiak G; Bechem M; Schramm M; Thomas G
Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
[TBL] [Abstract][Full Text] [Related]
15. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
Spedding M; Berg C
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
Nakaya H; Hattori Y; Tohse N; Kanno M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
[TBL] [Abstract][Full Text] [Related]
18. BAY-K-8644-stimulated cyclic GMP synthesis in mouse pituitary tumor cells.
Heisler S
J Pharmacol Exp Ther; 1986 Mar; 236(3):753-8. PubMed ID: 2419544
[TBL] [Abstract][Full Text] [Related]
19. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
Taira N; Wada Y; Satoh K
J Pharmacol Exp Ther; 1985 Jan; 232(1):244-50. PubMed ID: 2578189
[TBL] [Abstract][Full Text] [Related]
20. Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY K 8644.
Schramm M; Towart R; Lamp B; Thomas G
J Cardiovasc Pharmacol; 1985; 7(3):493-6. PubMed ID: 2410679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
